Common Causes |
Details |
Rheumatic Heart Disease |
Rheumatic heart disease (RHD) is the most common cause of mitral stenosis. It is caused by an immune response to streptococcal infections, leading to long-term inflammation and scarring of the mitral valve. |
Congenital Mitral Stenosis |
Some individuals are born with a congenital defect that leads to a narrowed mitral valve, often associated with other heart abnormalities. |
Mitral Annular Calcification |
Calcium deposits in the mitral valve annulus, particularly in elderly patients or those with chronic kidney disease, can cause narrowing of the valve. |
Rare Causes |
Details |
Radiation-Induced Mitral Stenosis |
Radiation therapy to the chest can lead to fibrosis of the mitral valve, causing stenosis years after treatment. |
Infective Endocarditis |
Endocarditis may lead to large vegetations or scarring on the valve leaflets, contributing to mitral stenosis. |
Lupus and Autoimmune Diseases |
Autoimmune conditions, such as systemic lupus erythematosus (SLE), may cause chronic inflammation and fibrosis of the mitral valve. |
Carcinoid Syndrome |
Carcinoid tumours can release substances like serotonin, leading to fibrotic changes in heart valves, including the mitral valve. |
Management Strategy |
Details |
Medical Management |
- Diuretics: To manage pulmonary congestion and fluid overload.
- Beta-blockers/Calcium Channel Blockers/Digoxin: To control heart rate, especially in atrial fibrillation.
- Anticoagulation: Mandatory for patients with atrial fibrillation to prevent thromboembolism. Warfarin or heparin is used; DOACs are contraindicated.
|
Percutaneous Mitral Balloon Valvotomy (PMBV) |
- Preferred for symptomatic patients with favorable valve anatomy.
- A balloon catheter is used to dilate the stenotic mitral valve, restoring normal blood flow.
- Best suited for younger patients without significant calcification or thickening of the valve.
|
Surgical Management |
- Mitral Valve Repair: For less severe valve damage.
- Mitral Valve Replacement: For severe cases, using either a mechanical or bioprosthetic valve.
|
Management of Atrial Fibrillation |
- Rate control with beta-blockers, calcium channel blockers, or digoxin.
- Rhythm control with antiarrhythmic drugs.
- Anticoagulation to prevent thromboembolic events.
|
Lifestyle Modifications |
- Salt Restriction: To reduce fluid retention and the workload on the heart.
- Exercise: Mild exercise is encouraged, but strenuous activity should be avoided.
- Regular Monitoring: Echocardiograms to monitor disease progression and adjust treatment accordingly.
|